Gary R. Sitko

Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.

Gary R. Sitko, Denise Ramjit, Inez I. Stabilito et al. · Circulation · 1992 · 131 citations · Full text

Metabolism-Directed Optimization of 3-Aminopyrazinone Acetamide Thrombin Inhibitors. Development of an Orally Bioavailable Series Containing P1 and P3 Pyridines

Christopher S. Burgey, Kyle A. Robinson, Terry A. Lyle et al. · Journal of Medicinal Chemistry · 2003 · 120 citations · Full text

Pharmaceutical Science, Oral Bioavailability, Pharmacotherapy +18

An Antibody Against the Exosite of the Cloned Thrombin Receptor Inhibits Experimental Arterial Thrombosis in the African Green Monkey

Jacquelynn J. Cook, Gary R. Sitko, Bohumil Bednář et al. · Circulation · 1995 · 94 citations

Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis.

Ronald J. Shebuski, I J Stabilito, Gary R. Sitko et al. · Circulation · 1990 · 67 citations · Full text

Arg-gly-asp-containing Peptide Bitistatin, Coronary Thrombosis, Biomedical Engineering +22

Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.

Joseph J. Lynch, Jacquelynn J. Cook, Gary R. Sitko et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 67 citations